Clinical Trial Update: ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar

View source ↗

Summary

An observational study evaluating Steqeyma, a biosimilar of ustekinumab, in patients with Crohn's disease and plaque psoriasis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis

Drugs mentioned

• STEQEYMA (USTEKINUMAB-STBA)

Snippet

Sponsor: Celltrion HealthCare France | Conditions: Crohn Disease, Plaque Psoriasis | Status: RECRUITING